Once in-person visits are possible and a person who was switched to an oral osteoporosis therapy is switched back to an injection, will there be any increased risks or impact on efficacy? The long-term impact is unknown, as we are in unchartered territory due to the pandemic, according to Williams. “But we know that the oral drugs help to preserve bone mass and bone strength, and it is safe to resume the injectable drugs,” she says.
“The pandemic has been unsettling to all of us, and our routines have been thrown off. With the stressors of these changes, it is easy to get out of the habit of taking medications as prescribed,” says Williams. If you are prescribed an oral medication, make sure you take it faithfully. Mark it on your calendar or set up reminders on your cell phone if need be, she says.
“If your appointment to receive an injectable osteoporosis medication has been delayed, stay in touch with your physician’s office and get rescheduled just as soon as they are able to see patients again,” she says.
It’s important to note that there is no evidence that osteoporosis drugs increase the risk or severity of COVID-19 infections, says Williams. “Unless a fracture occurs, osteoporosis is painless, so it can be easy to forget just how important it is to keep up with medications, supplements, and a healthy lifestyle. Be sure to take the time to take care of yourself,” she says.